Although the data suggest that IL-17 can reflect HCC occurrence in the next several years after baseline, the best performance was at year 1, with the highest area under the receiver operating characteristic curve (AUC = 0.762) and the lowest P-value (0.002). The gene discussed is IL17A; the disease is hepatocellular carcinoma.